Postes actifs de Alan R. Meyer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
OcuSub, Inc.
 OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Directeur/Membre du Conseil | 01/01/2018 | - |
| Fondateur | 01/01/2002 | - | |
| Directeur Général | 01/01/2002 | 01/01/2018 |
Historique de carrière de Alan R. Meyer
Anciens postes connus de Alan R. Meyer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OCUPHIRE PHARMA, INC. | Directeur/Membre du Conseil | - | 07/06/2021 |
| Fondateur | 01/02/2018 | 07/06/2021 | |
| AKSYS LTD. | Directeur/Membre du Conseil | - | 23/06/2006 |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Directeur/Membre du Conseil | 01/01/1992 | 01/01/2000 |
| Directeur Financier/CFO | 01/01/1992 | 01/01/2000 |
Formation de Alan R. Meyer
| University of Illinois | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Director/Board Member | 4 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AKSYS LTD. | Finance |
| OCUPHIRE PHARMA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
OcuSub, Inc.
OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Health Technology |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
- Bourse
- Insiders
- Alan R. Meyer
- Expérience
